12/13/2021 7:41:26 AM
Arbutus, Qilu Pharma Enter Licensing Deal To Develop AB-729 In Mainland China, Hong Kong, Macau And Taiwan
7/7/2021 7:15:41 AM
Arbutus Receives Authorization To Proceed With IND For AB-729 In A Phase 2a Clinical Trial
7/6/2021 7:09:35 AM
Arbutus Biopharma And Vaccitech Agree To Evaluate AB-729 In Combination With VTP-300 For Chronic HBV Infection
5/3/2021 7:06:06 AM
Eupraxia Pharma Appoints Bruce Cousins As President & CFO
8/6/2019 8:25:41 AM
Wedbush Is Raising Arbutus Biopharma Corp. (ABUS) FY21 Estimate To -0.84 From -1.00
8/6/2019 8:25:26 AM
Wedbush Is Raising Arbutus Biopharma Corp. (ABUS) Q4 21 Estimate To -0.17 From -0.20
8/6/2019 8:25:12 AM
Wedbush Is Raising Arbutus Biopharma Corp. (ABUS) Q3 21 Estimate To -0.21 From -0.25
8/6/2019 8:25:02 AM
Wedbush Is Increasing Arbutus Biopharma Corp. (ABUS) Q2 21 Estimate To -0.21 From -0.25
8/6/2019 8:24:47 AM
Wedbush Is Raising Arbutus Biopharma Corp. (ABUS) Q1 21 Estimate To -0.24 From -0.30
8/6/2019 8:24:33 AM
Wedbush Is Increasing Arbutus Biopharma Corp. (ABUS) FY20 Estimate To -1.00 From -1.23
8/6/2019 8:24:20 AM
Wedbush Is Raising Arbutus Biopharma Corp. (ABUS) Q4 20 Estimate To -0.24 From -0.30
8/6/2019 8:24:03 AM
Wedbush Is Increasing Arbutus Biopharma Corp. (ABUS) Q3 20 Estimate To -0.24 From -0.29